Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics is a clinical-stage oncology company developing small-molecule kinase inhibitors targeting oncogenic mutations.
10-QNov 16Latest SEC filing
Nov 9Latest story
November 2026
August 2026
Black Diamond Therapeutics is a clinical-stage oncology company developing small-molecule kinase inhibitors targeting oncogenic mutations.